文献速递关节外科运动医学

既往关节镜手术后的全肩关节置换术:病例对照匹配队列研究

Total Shoulder Arthroplasty After Previous Arthroscopic Surgery for Glenohumeral Osteoarthritis: A Case-Control Matched Cohort Study.
PubMed 文献 · Am J Sports Med · 2021-04-29

本研究比较了盂肱骨关节炎患者直接行全肩关节置换术(TSA)与既往关节镜综合管理(CAM)失败后行TSA(CAM-TSA)的结局。共匹配21例CAM-TSA与42例初次TSA患者,随访显示两组在术中失血量、手术时间、失败率及患者报告结局上均无显著差异。

要点

  • 既往CAM失败后行TSA与初次TSA在术中失血量、手术时间上无显著差异。
  • 两组失败率无显著差异(CAM-TSA 5.3% vs 初次TSA 8.1%,P > .999)。
  • 末次随访时两组所有患者报告结局评分均较术前显著改善,组间无显著差异。

核心结论

  • 对于严重盂肱骨关节炎患者,既往CAM失败后行TSA与直接行TSA相比,获益相似。

研究设计与样本

  • 病例对照匹配队列研究,证据等级3级;纳入小于70岁、术后至少2年的原发性TSA或CAM-TSA患者。
  • 21例CAM-TSA患者按年龄、性别和骨关节炎分级与42例原发性TSA患者匹配。

主要发现

  • 63例患者中56例(88.9%)获得随访,其中CAM-TSA组19例,原发性TSA组37例;平均年龄57.8岁(范围38.8-66.7岁)。
  • 术中失血量(P > .999)和手术时间(P = .127)组间无显著差异。
  • 4例(7.1%)发生失败,CAM-TSA组失败率5.3%(n=1),原发性TSA组8.1%(n=3),组间无显著差异(P > .999);另有2例因创伤行翻修关节置换术。
  • 50例未失败患者完成患者报告结局评估,平均随访4.8年(范围2.0-11.5年),CAM-TSA组平均4.4年(范围2.1-10.5年),原发性TSA组平均5.0年(范围2.0-11.5年),组间无显著差异(P = .164)。
  • 两组所有患者报告结局评分均较术前显著改善(P < .05);末次随访时组间中位数评分无显著差异:ASES 89.9(IQR 74.9-96.6)vs 94.1(IQR 74.9-98.3)(P = .545);SANE 84.0(IQR 74.0-94.0)vs 91.5(IQR 75.3-99.0)(P = .246);QuickDASH 9.0(IQR 3.4-27.3)vs 9.0(IQR 5.1-18.1)(P = .921);SF-12 PCS 53.8(IQR 50.1-57.1)vs 49.3(IQR 41.2-56.5)(P = .065);患者满意度9.5(IQR 7.3-10.0)vs 9.0(IQR 5.3-10.0)(P = .308)。

关键数值与推荐

  • CAM-TSA组与原发性TSA组在术中失血量、手术时间、失败率及患者报告结局评分上均无显著差异。

临床怎么用

  • 对于严格选择的盂肱骨关节炎患者,既往CAM失败不应视为后续TSA的禁忌,TSA仍可获得与初次TSA相似的结局。

局限性

  • 本研究为回顾性队列研究,证据等级3级,样本量较小(匹配后63例,随访56例),可能存在选择偏倚和混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: When comprehensive arthroscopic management (CAM) for glenohumeral osteoarthritis fails, total shoulder arthroplasty (TSA) may be needed, and it remains unknown whether previous CAM adversely affects outcomes after subsequent TSA. PURPOSE: To compare the outcomes of patients with glenohumeral osteoarthritis who underwent TSA as a primary procedure with those who underwent TSA after CAM (CAM-TSA). STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Patients younger than 70 years who underwent primary TSA or CAM-TSA and were at least 2 years postoperative were included. A total of 21 patients who underwent CAM-TSA were matched to 42 patients who underwent primary TSA by age, sex, and grade of osteoarthritis. Intraoperative blood loss and surgical time were assessed. Patient-reported outcome (PRO) scores were collected preoperatively and at final follow-up including the American Shoulder and Elbow Surgeons (ASES) score, Single Assessment Numeric Evaluation (SANE), shortened version of Disabilities of the Arm, Shoulder and Hand (QuickDASH), 12-Item Short Form Health Survey Physical Component Summary (SF-12 PCS), visual analog scale, and patient satisfaction. Revision arthroplasty was defined as failure. RESULTS: Of 63 patients, 56 of them (19 CAM-TSA and 37 primary TSA; 88.9%) were available for follow-up. There were 16 female (28.6%) and 40 male (71.4%) patients with a mean age of 57.8 years (range, 38.8-66.7 years). There were no significant differences in intraoperative blood loss (P > .999) or surgical time (P = .127) between the groups. There were 4 patients (7.1%) who had failure, and failure rates did not differ significantly between the CAM-TSA (5.3%; n = 1) and primary TSA (8.1%; n = 3) groups (P > .999). Additionally, 2 patients underwent revision arthroplasty because of trauma. A total of 50 patients who did not experience failure (17 CAM-TSA and 33 primary TSA) completed PRO measures at a mean follow-up of 4.8 years (range, 2.0-11.5 years), with no significant difference between the CAM-TSA (4.4 years [range, 2.1-10.5 years]) and primary TSA (5.0 years [range, 2.0-11.5 years]) groups (P = .164). Both groups improved significantly from preoperatively to postoperatively in all PRO scores (P < .05). No significant differences in any median PRO scores between the CAM-TSA and primary TSA groups, respectively, were seen at final follow-up: ASES: 89.9 (interquartile range [IQR], 74.9-96.6) versus 94.1 (IQR, 74.9-98.3) (P = .545); SANE: 84.0 (IQR, 74.0-94.0) versus 91.5 (IQR, 75.3-99.0) (P = .246); QuickDASH: 9.0 (IQR, 3.4-27.3) versus 9.0 (IQR, 5.1-18.1) (P = .921); SF-12 PCS: 53.8 (IQR, 50.1-57.1) versus 49.3 (IQR, 41.2-56.5) (P = .065); and patient satisfaction: 9.5 (IQR, 7.3-10.0) versus 9.0 (IQR, 5.3-10.0) (P = .308). CONCLUSION: Patients with severe glenohumeral osteoarthritis who failed previous CAM benefited similarly from TSA compared with patients who opted directly for TSA.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Nolte PC, Elrick BP, Arner JW, et al. Total Shoulder Arthroplasty After Previous Arthroscopic Surgery for Glenohumeral Osteoarthritis: A Case-Control Matched Cohort Study. Am J Sports Med. 2021. PMID: 33914650. doi:10.1177/03635465211006479

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。